Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study

Luís Antunes, Laurent Roche, Maria José Bento, GRELL EUROCARE-5 Working Group, Gemma Gatta, Milena Sant, Hade Amash, Lucia Mangone

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in age-standardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88% (Portugal and Spain) to 93% (Switzerland), whereas 5-year survival ranged between 72% (Portugal) and 79% (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5% at 1 year and 7% at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed.
Original languageEnglish
Pages (from-to)S100-S106
JournalEuropean Journal of Cancer Prevention
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Uterine Neoplasms
Survival
Portugal
Population
Switzerland
Belgium
Spain
Mortality
Italy
France
International Classification of Diseases
Uterus
Neoplasms
Databases

Keywords

  • Journal Article

Cite this

Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study. / Antunes, Luís; Roche, Laurent; José Bento, Maria; Group, GRELL EUROCARE-5 Working; Gatta, Gemma; Sant, Milena; Amash, Hade; Mangone, Lucia.

In: European Journal of Cancer Prevention, 01.01.2017, p. S100-S106.

Research output: Contribution to journalArticle

@article{e950e8c36b3c48099e49676560eaa73d,
title = "Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study",
abstract = "Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in age-standardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88{\%} (Portugal and Spain) to 93{\%} (Switzerland), whereas 5-year survival ranged between 72{\%} (Portugal) and 79{\%} (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5{\%} at 1 year and 7{\%} at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed.",
keywords = "Journal Article",
author = "Lu{\'i}s Antunes and Laurent Roche and {Jos{\'e} Bento}, Maria and Group, {GRELL EUROCARE-5 Working} and Gemma Gatta and Milena Sant and Hade Amash and Lucia Mangone",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/CEJ.0000000000000294",
language = "English",
pages = "S100--S106",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study

AU - Antunes, Luís

AU - Roche, Laurent

AU - José Bento, Maria

AU - Group, GRELL EUROCARE-5 Working

AU - Gatta, Gemma

AU - Sant, Milena

AU - Amash, Hade

AU - Mangone, Lucia

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in age-standardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88% (Portugal and Spain) to 93% (Switzerland), whereas 5-year survival ranged between 72% (Portugal) and 79% (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5% at 1 year and 7% at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed.

AB - Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in age-standardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88% (Portugal and Spain) to 93% (Switzerland), whereas 5-year survival ranged between 72% (Portugal) and 79% (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5% at 1 year and 7% at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed.

KW - Journal Article

U2 - 10.1097/CEJ.0000000000000294

DO - 10.1097/CEJ.0000000000000294

M3 - Article

SP - S100-S106

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

ER -